Couragene logo — Developing Gene and Biologic Therapies through Novel Deliver...

Couragene

Developing Gene and Biologic Therapies through Novel Delivery Platforms

Founded 2022 United States North Brunswick, United States 4 employees Biopharma, Biotechnology

General Information

Company Name Couragene
Founded Year 2022
Location United States North Brunswick, United States +1
Employees 4
Industries Biopharma, Biotechnology
Social

Get notified when Couragene moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Couragene

Couragene is a biopharmaceutical and biotechnology startup that is dedicated to developing gene and biologic therapies through novel delivery platforms. The company's slogan "Developing Gene and Biologic Therapies through Novel Delivery Platforms" encapsulates its commitment to advancing the delivery of genome modification therapies to the brain and overcoming physiological barriers. Founded in 2022 and headquartered in the United States, Couragene aims to revolutionize the treatment of various diseases, including neurogenetic disorders. The company's innovative STEP (Stimuli-responsive Traceless Engineering Platform) technology has shown promising potential in surmounting the challenges associated with the delivery of gene and biologic therapies. Couragene believes that making the delivery of these therapies safer and more efficient is essential for the advancement of medical treatment in the field of biopharma and biotechnology. Thus far, Couragene has not disclosed its last investment or the entities involved, but its groundbreaking approach to addressing the obstacles in delivering gene and biologic therapies positions the company as a potential game-changer in the industry.

Taxonomy: Gene therapy, Biologic therapy, Delivery platforms, STEP technology, Neurogenetic disorders, Non-viral gene therapy, CRISPR, Oral drug delivery, Genome editing, DNA/RNA delivery, ASO delivery, Gene disruption, Epigenetic regulation, Rare diseases

No funding data available for Couragene yet.

Get notified when Couragene raises funding

Couragene Alternatives & Competitors

Couragene vs

Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies

Seed
5 employees
Biopharma, Biotechnology
Couragene vs

PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapi...

Seed
9 employees
Biotechnology, Health and Wellness
Couragene vs

Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.

Private Equity
74 employees
Biotechnology, Health Care
Also compare with: Couragene vs Nanotransfer Nanotransfer

FAQ About Couragene

Developing Gene and Biologic Therapies through Novel Delivery Platforms
Couragene was founded in 2022.
Couragene is headquartered in North Brunswick, United States.
Couragene operates in the following industries: Biopharma, Biotechnology.
Couragene has approximately 4 employees.
Top alternatives and competitors to Couragene include Basilard BioTech, Inc., PulseSight Therapeutics, Kelonia Therapeutics, Nanotransfer, AlveoGene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Couragene and Basilard BioTech, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Couragene and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes